This message was sent to ##Email##
|
|
|
|
|
| |
NBC News
You drag yourself from your desk to the gym, where you pop in some upbeat music and jack the treadmill up to 6 mph.
Admit it, while your pounding out those three miles, you’re silently judging (even if subconsciously) the person walking next to you.
What a waste of time. Why even come to the gym if you’re just going to walk? But experts say we’re unfairly placing the form of exercise in the “pointless” category. It turns out, you may be missing out on an extremely effective physical activity, not to mention a mental boost, by writing off walking entirely.
READ MORE
The New York Times
Being active in youth may change the inner workings of brain cells much later in life and sharpen some types of thinking, according to a remarkable new neurological study involving rats.
The study suggests that the effects of youthful exercise on the brain could linger deep into adulthood, potentially providing a buffer against the declines in brain health and memory that otherwise occur with age.
READ MORE
Reuters
People with higher incomes tend to be “weekend warriors,” who are sedentary much of the time but exercise a lot on their days off, a recent U.S. study suggests.
Plenty of previous research has linked affluence to a higher likelihood of intense physical activity and more time devoted to exercise compared to people with lower incomes.
READ MORE
NBC News
We think about it. And maybe even set the alarm with the expectation of a sunrise run, but most of us don't exercise early, despite our best intentions. Yet the 69 percent of exercisers who work out after noon might be missing out on some key benefits of moving in the morning.
Exercise physiologists say any time of day is valuable for a workout as long as you do it, but the fact is, few do.
READ MORE
Inc.
Max Lowery, 27, recently told us why he would never touch a protein shake, even if you paid him.
Now, the stockbroker turned personal trainer and founder of the "2-Meal Day diet" wants to iron out some more common fitness misconceptions that could be making your workout less effective.
READ MORE
Popular Science
From the glorious gluttony that is the turducken, to the gustatory pleasures that make up so many Instagram photos, Americans sure do know how to eat. What to eat — that is, what we should be eating to stay healthy — remains somewhat elusive. We’re told that veganism, the meat-heavy Paleo Diet, and the somewhere-in-the-middle Mediterranean diet are all good for us, contradictions be damned.
READ MORE
HealthDay News via CBS News
A large, 18-country study may turn current nutritional thinking on its head.
The new research suggests that it's not the fat in your diet that's raising your risk of premature death, it's too many carbohydrates — especially the refined, processed kinds of carbs — that may be the real killer.
READ MORE
The Washington Post via Chicago Tribune
Over the years, Robert Kushner has seen many obese patients get "tripped up" trying to keep pounds off because they rely on fast food, juggle too many tasks and dislike exercise.
So Kushner, an obesity expert, began helping patients plan diet and physical activity around their lifestyles and habits. "We don't necessarily put people on any specific diet; it really gets to what is their life, what are their struggles," he said.
READ MORE
The Washington Post
Casey Seidenberg writes: For the first time in his 14 years, my oldest son brought home the bacon with two paid summer jobs. Boy, did he relish in the reward of the paycheck. He has always spent whatever money he acquired through birthdays or allowance on the newest baseball glove, the hottest pair of basketball shoes or, dare I say it, candy. But this summer, he said there was something about devoting long days to work that made him want to save his pennies.
READ MORE
WebMD
Americans spend billions of dollars a year on protein supplements to build muscle or lose weight, or because they think it’s a healthy thing to do.
But do you really need all that protein, and are the powders and supplements safe? Questions about their safety came up following the death of 25-year-old-Australian bodybuilder Meegan Hefford, who ate a high-protein diet that included protein supplements.
READ MORE
Plataforma SINC via ScienceDaily
Researchers have clarified doubts over the physical activity recommended during pregnancy. Their work highlights how exercise should be taken not only by healthy, previously active women, but that it is also a good time to adopt a healthy lifestyle. There are clear advantages for both the mother and baby.
READ MORE
| | VITAMINS & PHARMACEUTICALS |
Business Insider
They're colorful, chewable, and more affordable than a doctor's visit. And if you believe some of their claims, supplements can do everything from giving you an energy boost to helping you lose weight. At the very worst, your daily tablet can't do any harm — right?
Not so fast. A growing body of research suggests that some supplements can carry real health risks that range from vomiting to negative interactions with existing medications and even an increased risk of cancer and death.
READ MORE
| |
MISSED AN ISSUE OF ENEWS ON PREVENTION, WELLNESS & LIFESTYLE? VISIT AND SEARCH THE ARCHIVE TODAY. |
Reader's Digest
There are a lot of reasons to make sure you get enough of the eight B vitamins, all of which are said to increase energy, and two of which — B6 and B12 — are said to support production of serotonin, which is crucial to avoiding and overcoming depression. These are the signs you could be deficient in B vitamins.
READ MORE
|
| Jazz Pharmaceuticals is proud to announce that VYXEOS has been approved by the US Food and Drug Administration (FDA) for the treatment of adults with therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC). Please click here for more information. |
| Puma Biotechnology, Inc. today announced that the U.S. FDA has approved NERLYNX™ (neratinib), a once-daily oral tyrosine kinase inhibitor for the extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancer, following adjuvant trastuzumab-based therapy. Please click here for more details and the full press release. |
| Seattle Genetics and Takeda Announce Positive Results from Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS® (brentuximab vedotin) in Frontline Advanced Hodgkin Lymphoma. The companies announced that the phase 3 ECHELON-1 clinical trial met its primary endpoint of a statistically significant improvement in modified progression-free survival (PFS) versus the control arm. Click here to view the full press release. |
| Join Zitter Health Insights’ (ZHI) research panel and earn honoraria - paid directly to you or to your favorite charity. ZHI provides innovative insights that help optimize patient access to pharmaceuticals. We work for and with life science companies, specialty pharmacies and managed healthcare organizations across the US. For nearly 30 years, our syndicated research and expertise have helped customers solve market access challenges. This research helps IDNs exercise greater influence over how the pharmaceutical industry approaches and interacts with them. We are recruiting IDN executives to participate in our research and your knowledge is paramount to providing key stakeholders with insights into the challenging issues involved with pharmaceutical access. We look forward to your participation in this important dialogue. Yes, I’d like to learn more and participate! |
| CVS Health today announced the company will launch Reduced Rx™, a prescription savings program that will offer discounts on certain medications – through CVS Health’s pharmacy benefits manager, CVS Caremark – directly to patients. The program will help patients with high out of pocket costs afford essential medications. Novo Nordisk will participate in the prescription savings program. Through this program, CVS Health and Novo Nordisk will offer Novolin R®, Novolin N® and Novolin 70/30® human insulin at a cost of $25 per 10ml vial, which reflects a potential savings of as much as $100 for cash paying patients. Click here for more information. |
| Intarcia Therapeutics, Inc. is a rapidly emerging biopharmaceutical company committed to developing innovative therapies utilizing the Medici Drug Delivery System™ – therapies that have the potential to transform the prevention and management of serious chronic diseases. Across chronic diseases, medication non-adherence can compromise clinical outcomes and drive excess cost to the healthcare system. Intarcia is working to address this problem through innovative technologies. We invite you to visit our website to learn more. |
| The National Institute for Health and Care Excellence (NICE) issued positive guidance recommending the use of the HeartFlow FFRct Analysis to help determine the cause of stable chest pain in patients. The HeartFlow FFRct Analysis is the first non-invasive technology to provide insight into both the extent of coronary artery disease and the impact that disease has on blood flow to the heart, aiding clinicians in selecting an appropriate treatment. Please click here to view the full press release. |
| Last month, Novo Nordisk received approval from the US Food and Drug Administration for the New Drug Application (NDA) for Xultophy® 100/3.6. Xultophy® 100/3.6 is a combination of insulin degludec and liraglutide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus inadequately controlled on basal insulin or liraglutide. The FDA has required Novo Nordisk to distribute the safety notice as part of the Xultophy® 100/3.6 REMS program. Click Here for the Letter. Click Here for the fact sheet. |
| Courtagen Life Sciences, Inc., an innovative molecular information company focused on providing genetic diagnoses for neurological conditions through next generation sequencing, offers a broad range of genetic testing panels for epilepsy, including recently-added epiSEEK® Spotlight Panels designed to target genes that have been reported in association with specific phenotypes for epilepsy and seizure disorders. Please click here for more information. |
| New iOn PROGRESS™ Remote Therapy Monitoring system from Acelity marks first continuous monitoring and ready intervention for patients receiving negative pressure wound therapy at home, and supports patient compliance. Non-compliance can lead to unnecessary spending for excessive hospital readmissions ,and unnecessary ER visits. Please click here to review the full press release. |
| Based on published clinical data, Humana, Medical Mutual of Ohio and Preferred One independently determined and published policies stating that Biodesix’ VeriStrat® test can be considered medically necessary for patients with advanced NSCLC. The VeriStrat test provides physicians with prognostic and predictive information to inform treatment of advanced NSCLC, and can facilitate patient-physician conversations about prognosis, life expectancy, and treatment recommendations. Click here for more information. |
Check out JMCM’s new website at www.jmcmpub.org
|
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
